Maternal Opioid Prescriptions During Pregnancy Associated With Increased Childhood Hospital Admissions

Prescription opioids are medicines used to treat certain types of moderate to severe pain. Although these medications can have an important role in medical treatment, their use during pregnancy requires careful assessment because both the medication and the underlying maternal condition may influence pregnancy and child health. A nationwide observational study in South Korea examined health records for approximately 2.93 million children born between 2010 and 2017. Researchers followed the children for as long as 14 years to investigate whether opioid prescriptions during pregnancy were associated with later childhood hospital admissions. Prenatal exposure was identified when mothers received at least two opioid prescriptions during pregnancy. The study found that exposed children had an adjusted hospital-admission rate approximately 28% higher than that of children without documented prenatal exposure. When researchers compared siblings within the same family, the association became considerably smaller, although it remained statistically significant. The higher admission rates involved several categories of illness, including infections and respiratory, gastrointestinal, and genitourinary conditions. The association was strongest during the first five years of life. The researchers also reported that higher opioid doses were associated with higher admission rates. However, the study was observational and cannot establish that the medications themselves caused the later health problems. Important limitations include the possibility that prescription records do not accurately represent actual medication use. Maternal health conditions, family circumstances, other medications, and other unmeasured factors may also influence children's health. Prenatal opioid exposure can raise concerns about newborn withdrawal symptoms and other effects, depending on the medication, dose, timing, and pattern of exposure. However, the childhood hospitalization study should not be interpreted as proof that every child exposed to prescribed opioids will develop complications. Medical significance: Pregnant patients should discuss pain management options with their healthcare professionals rather than independently stopping or changing prescribed medication. Children with relevant prenatal exposure may benefit from individualized developmental and medical follow-up based on their clinical circumstances.